Lori Wood

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.

F. Saad, A. Kapoor, S. Hotte, 2011, Current oncology.

Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.

S. Pautler, R. Kim, M. Care, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).